Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.
Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...
Clinical Trials Arena on MSN1d
Epicrispr secures $68m for facioscapulohumeral muscular dystrophy therapy trialEpicrispr has raised $68m in the initial close of its Series B financing round to commence the clinical trial of EPI-321 for ...
Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...
CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.
One of the most crucial aspects of psychedelic therapy is the process of making meaning from psychedelic experiences and ...
Eli Lilly (LLY) stock in focus as an expert panel of the EU drug regulator declines to endorse its Alzheimer's drug Kisunla.
BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...
Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.
Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...
The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...
FRANKLIN COUNTY, Va. (WSET) — A new wellness business is now open in Smith Mountain Lake. Nourished Westlake IV Drip Bar and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback